Logo image of DMRC

DIGIMARC CORP (DMRC) Stock Fundamental Analysis

NASDAQ:DMRC - Nasdaq - US25381B1017 - Common Stock - Currency: USD

13.28  +0.19 (+1.45%)

After market: 13.28 0 (0%)

Fundamental Rating

3

Overall DMRC gets a fundamental rating of 3 out of 10. We evaluated DMRC against 281 industry peers in the Software industry. While DMRC has a great health rating, there are worries on its profitability. DMRC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year DMRC has reported negative net income.
In the past year DMRC has reported a negative cash flow from operations.
DMRC had negative earnings in each of the past 5 years.
In the past 5 years DMRC always reported negative operating cash flow.
DMRC Yearly Net Income VS EBIT VS OCF VS FCFDMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

DMRC's Return On Assets of -51.49% is on the low side compared to the rest of the industry. DMRC is outperformed by 81.85% of its industry peers.
DMRC's Return On Equity of -63.58% is on the low side compared to the rest of the industry. DMRC is outperformed by 71.53% of its industry peers.
Industry RankSector Rank
ROA -51.49%
ROE -63.58%
ROIC N/A
ROA(3y)-53.7%
ROA(5y)-52%
ROE(3y)-66.35%
ROE(5y)-62.86%
ROIC(3y)N/A
ROIC(5y)N/A
DMRC Yearly ROA, ROE, ROICDMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 60.24%, DMRC is in line with its industry, outperforming 41.28% of the companies in the same industry.
In the last couple of years the Gross Margin of DMRC has declined.
The Profit Margin and Operating Margin are not available for DMRC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.43%
GM growth 5Y-1.52%
DMRC Yearly Profit, Operating, Gross MarginsDMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

8

2. Health

2.1 Basic Checks

DMRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DMRC has more shares outstanding
DMRC has more shares outstanding than it did 5 years ago.
There is no outstanding debt for DMRC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DMRC Yearly Shares OutstandingDMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
DMRC Yearly Total Debt VS Total AssetsDMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 4.62 indicates that DMRC is not in any danger for bankruptcy at the moment.
DMRC has a better Altman-Z score (4.62) than 69.75% of its industry peers.
There is no outstanding debt for DMRC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.62
ROIC/WACCN/A
WACC10.44%
DMRC Yearly LT Debt VS Equity VS FCFDMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M

2.3 Liquidity

DMRC has a Current Ratio of 4.30. This indicates that DMRC is financially healthy and has no problem in meeting its short term obligations.
DMRC has a better Current ratio (4.30) than 81.85% of its industry peers.
DMRC has a Quick Ratio of 4.30. This indicates that DMRC is financially healthy and has no problem in meeting its short term obligations.
DMRC has a better Quick ratio (4.30) than 81.85% of its industry peers.
Industry RankSector Rank
Current Ratio 4.3
Quick Ratio 4.3
DMRC Yearly Current Assets VS Current LiabilitesDMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.90% over the past year.
DMRC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.26%.
The Revenue has been growing by 10.82% on average over the past years. This is quite good.
EPS 1Y (TTM)22.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
Revenue 1Y (TTM)10.26%
Revenue growth 3Y13.15%
Revenue growth 5Y10.82%
Sales Q2Q%-6.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y57.03%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-12.02%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DMRC Yearly Revenue VS EstimatesDMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DMRC Yearly EPS VS EstimatesDMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DMRC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DMRC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DMRC Price Earnings VS Forward Price EarningsDMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DMRC Per share dataDMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DMRC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DIGIMARC CORP

NASDAQ:DMRC (5/1/2025, 8:56:22 PM)

After market: 13.28 0 (0%)

13.28

+0.19 (+1.45%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-05 2025-05-05
Inst Owners63.6%
Inst Owner Change0.68%
Ins Owners12.29%
Ins Owner Change1.35%
Market Cap286.18M
Analysts80
Price Target28.05 (111.22%)
Short Float %11.87%
Short Ratio6.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.98%
Min EPS beat(2)-22.81%
Max EPS beat(2)20.85%
EPS beat(4)3
Avg EPS beat(4)7.25%
Min EPS beat(4)-22.81%
Max EPS beat(4)20.85%
EPS beat(8)7
Avg EPS beat(8)10.77%
EPS beat(12)10
Avg EPS beat(12)11.83%
EPS beat(16)13
Avg EPS beat(16)8.54%
Revenue beat(2)0
Avg Revenue beat(2)-11.05%
Min Revenue beat(2)-13.29%
Max Revenue beat(2)-8.81%
Revenue beat(4)2
Avg Revenue beat(4)-4.89%
Min Revenue beat(4)-13.29%
Max Revenue beat(4)1.75%
Revenue beat(8)5
Avg Revenue beat(8)-2.15%
Revenue beat(12)6
Avg Revenue beat(12)-2.52%
Revenue beat(16)8
Avg Revenue beat(16)-1.63%
PT rev (1m)0%
PT rev (3m)-19.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-47.55%
EPS NY rev (1m)0%
EPS NY rev (3m)44.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-26.58%
Revenue NY rev (1m)-16.29%
Revenue NY rev (3m)-29.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.45
P/FCF N/A
P/OCF N/A
P/B 4.66
P/tB 9.34
EV/EBITDA N/A
EPS(TTM)-1.01
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-1.26
FCFYN/A
OCF(TTM)-1.23
OCFYN/A
SpS1.78
BVpS2.85
TBVpS1.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.49%
ROE -63.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.24%
FCFM N/A
ROA(3y)-53.7%
ROA(5y)-52%
ROE(3y)-66.35%
ROE(5y)-62.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.43%
GM growth 5Y-1.52%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.47%
Cap/Sales 1.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.3
Quick Ratio 4.3
Altman-Z 4.62
F-Score6
WACC10.44%
ROIC/WACCN/A
Cap/Depr(3y)12.3%
Cap/Depr(5y)36.87%
Cap/Sales(3y)2.89%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
EPS Next Y57.03%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.26%
Revenue growth 3Y13.15%
Revenue growth 5Y10.82%
Sales Q2Q%-6.74%
Revenue Next Year-12.02%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.81%
OCF growth 3YN/A
OCF growth 5YN/A